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ABSTRACT
The integron content of Gram-negative strains implicated in three distinct episodes of suspected cross-
infection among inpatients was investigated and compared with ribotyping. In the ﬁrst episode,
ribotyping identiﬁed a strain of Acinetobacter, isolated over a 3-month period, responsible for an
outbreak associated with the use of mechanical ventilation in the intensive care unit (ICU). The second
episode concerned simultaneous isolations of Pseudomonas aeruginosa and Serratia marcescens from
13 bronchoscopy patients. In these two episodes, results obtained by analysis of integron content and
ribotyping were in agreement and correctly identiﬁed the epidemiologically related strains. In the third
episode, isolates of Enterobacter cloacae were collected from patients in the neonatal ICU over a 3-month
period. Although several isolates belonged to the same ribotype, cross-infection could not always be
conﬁrmed when the integron content was analysed. Integron detection can be considered a useful tool
for studying molecular epidemiology in hospital environments, facilitating the quick detection of
possible cross-infection cases, especially in critical wards such as the ICU.
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INTRODUCTION
Integrons belong to a class of genetic structures
that contain one or more gene cassettes inserted at
a speciﬁc site [1]. They are deﬁned by the presence
of an integrase gene (intI), a recombination site
(attI), and one or two promoters responsible for
expression of the inserted gene cassettes. Gene
cassettes include an open reading frame and a
recombination site, 59-bp element or attC [2,3].
Integration and excision of cassettes occurs by a
site-speciﬁc recombination mechanism catalysed
by the integrase [4]. Based on the intI sequences, at
least six classes of integrons have been described to
date [5–9]. Class 1 integrons are the most studied
and are largely implicated in the dissemination of
antibiotic resistance among clinical isolates [10,11].
Although the mobilisation of gene cassettes has
been demonstrated on various occasions [12], the
stability of integron structures has been indicated
by the ﬁnding of conserved gene cassette combi-
nations among isolates of different origins, or their
maintenance in bacteria under antibiotic pressure
over extended periods of time [13,14].
Numerous hospital outbreaks of multiresistant
strains of Pseudomonas aeruginosa and Acinetobacter
spp. have been investigated by molecular typing
methods, and evidence of nosocomial transmis-
sion has been gathered repeatedly [15–19]. Serratia
marcescens, a well known cause of nosocomial
infections [20,21], also requires genotypic char-
acterisation for systematic surveillance [22,23].
Hospital infections associated with Enterobacter
cloacae, an emergent pathogen in hospitalised
patients, frequently arise through endogenous
translocation from the digestive tract [24,25].
Nosocomial outbreaks caused by this bacterium
are usually related to cross-infection or cross-
colonisation via hospital materials and ⁄ or the
hands of personnel, highlighting the need for
discriminatory molecular typing methods [26].
In the present study, the detection and charac-
terisation of integrons was investigated as a tool
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for the discrimination of epidemiologically related
strains. Ribotyping and epidemiological data were
used to elucidate cross-contamination or common
sources of contamination among inpatients during
three possible outbreak episodes, and then com-
pared with the integron proﬁles of the isolates.
MATERIALS AND METHODS
Bacterial strains
Three groups of bacteria involved in possible cross-infection
episodes at Hospital Albert Einstein, Sa˜o Paulo, Brazil were
included in the present study. Isolates were identiﬁed with the
Vitek system (BioMe´rieux, Hazelwood, MO, USA), and their
genotypic relationships were investigated by ribotyping, as
described previously [18,22,27].
Group 1 comprised 17 strains of Acinetobacter isolated in
November 1992 to April 1993 from mechanically ventilated
patients. Nine of these strains and one additional strain of non-
respiratory origin were included in this group as controls for
the assessment of integron variation among epidemiologically
unrelated strains. All Acinetobacter strains were also tested for
susceptibility (Vitek system) to ampicillin, aztreonam, car-
benicillin, ciproﬂoxacin, imipenem, mezlocillin, piperacillin,
ticarcillin, ticarcillin–clavulanate, trimethoprim–sulphameth-
oxazole, amikacin, cefazolin, cefotetan, ceftazidime, ceftriax-
one, cefuroxime, cephalothin, gentamicin and tobramycin.
Group 2 involved the concurrent isolation of P. aeruginosa
and S. marcescens strains from bronchoscopy patients in
March–August, 1996.
Group 3 comprised nine E. cloacae strains isolated from the
neonatal intensive care unit (NICU) over a 3-month period in
1995.
Detection and analysis of integrons
DNA templates for PCRwere prepared by amodiﬁcation of the
method described by Le´vesque and Roy [28]. Brieﬂy, cells were
incubated overnight in 3 mL of YT broth (yeast extract plus
tryptone; ICN Biomedicals, Costa Mesa, CA, USA), washed
with distilled water, and resuspended in 1 mL of distilled
water. This suspension was used as the PCR template. PCRs
were carried out in 50-lL volumes containing 200 lM dNTPs
(Amersham Pharmacia Biotech, Milwaukee, WI, USA),
50 pmol of each primer (Amersham Pharmacia Biotech),
1 · PCR buffer (Amersham Pharmacia Biotech), 3 mM MgCl2,
2.5 U of Taq DNA polymerase (Amersham Pharmacia Biotech),
and 5 lL of freshly prepared bacterial suspension. The oligo-
nucleotide primers (3¢-CS and 5¢-CS) described by Le´vesque
and Roy [28] were directed to the conserved segments of
integrons. Ampliﬁcation was performed in a Gene Amp 9600
thermal cycler (Perkin Elmer Applied Biosystems, Foster City,
CA, USA) as follows: 10 min at 95 C; 12 cycles of 1 min at
94 C, 1 min at 55 C and 5 min at 72 C; 12 cycles of 1 min at
94 C, 1 min at 55 C and 6 min at 72 C; and 12 cycles of 1 min
at 94 C, 1 min at 55 C and 7 min at 72 C. This is a
modiﬁcation of the protocol proposed by Le´vesque and Roy
[28]. PCR products were visualised under UV light after
electrophoresis at 5 V ⁄ cm for 2 h on agarose (ICN Biomedicals)
1.2% w ⁄v gels and staining with ethidium bromide. Primers
complementary to conserved regions of the 16S and 23S
ribosomal RNA genes (rRNA) were used as described by
Kostman et al. [29] to demonstrate the integrity of the DNA
template and the absence of PCR inhibitors, thus validating
negative results.
When similar-sized integrons were ampliﬁed, a comparison
of inserted cassettes was performed by digestion of 10 lL of
PCR products with RsaI and Sau3AI, following the manufac-
turer’s recommendations (Gibco BRL Life Technologies, Rock-
ville, MD, USA).
RESULTS
Episode 1
Sixteen patients were enrolled in this study
(Table 1). Thirteen were under intensive care and
were infected or colonised by Acinetobacter
acquired after hospitalisation. Ribotyping sugges-
ted that a strain of Acinetobacter (ribotype R1;
Table 1), isolated over a 3-month period, was
responsible for an outbreak, and epidemiological
data correlated its isolation with the use of
mechanical ventilation. One additional patient,
with an Acinetobacter strain isolated from a vaginal
sample during the outbreak period, was included
in the study as an external control. Post-outbreak
isolates were ribotyped and found to be distinct
from the strain implicated in the outbreak. All
tested strains were susceptible to ciproﬂoxacin,
imipenem, ceftazidime and ceftriaxone. There was
an identical pattern of resistance among all Acine-
tobacterR1 strains,with two exceptions, AC109 and
AC101. The resistance proﬁle of strain AC141, the
R1 strain isolated after the episode, also matched
the proﬁle of the outbreak strain (Table 1).
Detection and analysis of integron content
showed a good correlation with the ribotyping
results and resistance proﬁles. Isolates that were
not involved in the outbreak had distinct integron
patterns (Fig. 1), including the R1 strain collected
and identiﬁed after the episode. Integron charac-
terisation helped in the discrimination of strains,
since it correctly grouped strains that were epi-
demiologically linked.
Episode 2
Simultaneous isolates of P. aeruginosa and
S. marcescens from bronchoalveolar lavage ﬂuid
between March and October 1996 were exam-
ined by ribotyping. A strain of P. aeruginosa
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(ribotype R49) and one of S. marcescens (ribotype
R1) were both isolated from 13 patients with no
other signs of respiratory tract infection (Table 2).
Analysis of epidemiological data from the patients,
and ribotyping of isolates collected from
bronchoscope-related equipment, helped in the
characterisation of a pseudo-outbreak related to
the inappropriate manual disinfection of the
bronchoscope. The implementation of more strict
disinfection procedures successfully controlled
the situation.
The integron content of patient and control
strains was assessed (Table 2; Fig. 2). Since nei-
ther P. aeruginosa R49 nor S. marcescens R1 strains
were isolated in the hospital after this pseudo-
outbreak, the controls were three strains of
P. aeruginosa isolated during the same period,
but presenting a distinct ribotype (R7). Several
patients from whom only P. aeruginosa R49 had
been isolated after bronchoscopy were also inclu-
ded in the study. All had the same integron
content, suggesting an identical source of con-
tamination. The P. aeruginosa R7 strains had
different integron patterns.
Episode 3
From August to October 1995, isolates of E. cloacae
were collected from nine inpatients of the
NICU (Table 3). Seven isolates were of the
same ribotype (R4). Ribotypes R5 and R6 were
also identiﬁed during the same period. Integron
Table 2. Ribotyping, epidemiological data and integron analysis of Pseudomonas aeruginosa and Serratia marcescens strains
involved in a pseudo-outbreak (episode 2)
Patient
Strain PA ⁄
ribotype
Strain SM ⁄
ribotype
Date of
isolation
Integron
RFLP
PA ⁄SM
Site of
isolation
Clinical
ward
P1 PA1095 ⁄R7 – 14 ⁄ 12 ⁄ 1995 A ⁄ – BAL Oncology
P2 PA1115 ⁄R7 – 16 ⁄ 01 ⁄ 1996 A ⁄ – BAL ICU
P3 PA1120 ⁄R7 – 22 ⁄ 01 ⁄ 1996 A ⁄ – BAL GC
P4 PA1159 ⁄R49 – 12 ⁄ 03 ⁄ 1996 B ⁄ – BAL PW
P5 PA1162 ⁄R49 SM37 ⁄R1 16 ⁄ 03 ⁄ 1996 B ⁄C BAL GC
P6 PA1168 ⁄R49 SM38 ⁄R1 19 ⁄ 03 ⁄ 1996 B ⁄C BAL SICU
P7 PA1181 ⁄R49 – 31 ⁄ 03 ⁄ 1996 B ⁄ – BAL Oncology
P8 PA1179 ⁄R49 SM39 ⁄R1 02 ⁄ 04 ⁄ 1996 B ⁄C BAL GC
P9 PA1203 ⁄R49 SM43 ⁄R1 23 ⁄ 04 ⁄ 1996 B ⁄C BAL Oncology
P10 PA1204 ⁄R49 SM55 ⁄R1 25 ⁄ 04 ⁄ 1996 B ⁄C BAL ICU
P11 PA1211 ⁄R49 – 30 ⁄ 04 ⁄ 1996 B ⁄ – BAL ICU
P12 PA1218 ⁄R49 – 07 ⁄ 05 ⁄ 1996 B ⁄ – BAL GC
P13 PA1221 ⁄R49 SM64 ⁄R1 08 ⁄ 05 ⁄ 1996 B ⁄C BAL Oncology
P14 PA1226 ⁄R49 SM69 ⁄R1 13 ⁄ 05 ⁄ 1996 B ⁄C BAL GC
P15 PA1227 ⁄R49 SM71 ⁄R1 14 ⁄ 05 ⁄ 1996 B ⁄C BAL GC
P16 PA1230 ⁄R49 SM72 ⁄R1 15 ⁄ 05 ⁄ 1996 B ⁄C BAL ICU
P17 PA1231 ⁄R49 SM82 ⁄R1 16 ⁄ 05 ⁄ 1996 B ⁄C BAL ICU
P18 PA1234 ⁄R49 – 17 ⁄ 05 ⁄ 1996 B ⁄ – BAL ICU
P19 PA1256 ⁄R49 SM84 ⁄R1 11 ⁄ 06 ⁄ 1996 B ⁄C BAL SICU
P20 PA1286 ⁄R49 – 06 ⁄ 07 ⁄ 1996 B ⁄ – BAL GC
P21 PA1334 ⁄R49 SM91 ⁄R1 06 ⁄ 08 ⁄ 1996 B ⁄C BAL GC
P22 PA1344 ⁄R49 SM116 ⁄R1 21 ⁄ 08 ⁄ 1996 B ⁄C BAL Oncology
P23 PA1350 ⁄R49 – 25 ⁄ 08 ⁄ 1996 B ⁄ – BAL PW
Bronchoscope PA1274 ⁄R49 – 24 ⁄ 06 ⁄ 1996 B ⁄ – Water –
P, patient; PA, P. aeruginosa; R, ribotype; SM, S. marcescens; BAL, bronchoalveolar lavage; ICU, intensive care unit; GC,
general clinic; PW, paediatric ward; SICU, Semi-intensive care unit.
1    2      3     4    5     6     7    8     9   10    11  12
23 kb
2.0 kb
564 bp
Fig. 1. PCR ampliﬁcation products obtained with the 3¢-CS
and 5¢-CS primers with Acinetobacter spp. (episode 1).
Lanes: 1, AC97; 2, AC101; 3, AC99; 4, AC100; 5, AC105; 6,
AC106; 7, AC104; 8, AC118; 9, AC119; 10, AC128; 11,
AC141; 12, lambda DNA HindIII size marker.
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analysis was used to further characterise the
strains of interest. Five of the seven strains
belonging to ribotype R4 and isolated in August
and September did not harbour integrons, while
the other two, isolated in October, had the same
integron content. Cross-colonisation between ﬁve
of the nine newborns (P1, P2, P3, P4 and P5) can
be inferred, and was probably associated with
inappropriate disinfection of hands and ⁄ or mater-
ial by personnel. It is likely that patients P7 and P9
also shared identical strains. Although precau-
tionary measures to prevent cross-contamination
were probably disregarded, the integron diversity
detected among isolates of the same ribotype (R4)
indicated that there was no common source of
infection for all seven newborns.
DISCUSSION
The genetic characteristics of integrons strongly
imply that they are ﬂuid structures capable of
rapidly integrating and excising gene cassettes.
This has been veriﬁed experimentally, and a
series of integron-associated gene cassettes enco-
ding resistance to commonly-used antibiotics has
been identiﬁed among clinical isolates of entero-
bacteria and pseudomonads [30–32]. On the other
hand, indistinguishable integron proﬁles were
obtained among Salmonella enterica strains isola-
ted 10 years apart in the USA, pointing to the
stability of some integron structures and their
usefulness as epidemiological markers [33].
Sequencing has also revealed a high prevalence
of genes conferring resistance to streptomycin
and spectinomycin among integrons, even
though such antibiotics are no longer in wide-
spread clinical use [14,34,35]. Additionally, the
characterisation of integrons carried by bacteria
present in speciﬁc clinical wards has led to
interesting conclusions concerning the mainten-
ance of integrons among bacterial genotypes
and ⁄ or hospital environments [13,36,37].
The broad dissemination of integrons among
clinical isolates, coupled with the relative stability
1     2     3      4      5      6     7       8       9    10 1    2    3     4     5    6     7    8    9  10  11  12  13  14 
23 kb
2.0 kb
564 bp
2.0 kb
564 bp
(a) (b)
Fig. 2. PCR ampliﬁcation products obtained with primers 3¢-CS and 5¢-CS (episode 2). (a) Lanes 1–13, integrons detected in
strains of Pseudomonas aeruginosa PA1162, PA1168, PA1179, PA1203, PA1204, PA1221, PA1226, PA1227, PA1230, PA1231,
PA1256, PA1334, PA1274; lane 14, lambda DNA HindIII size marker. (b) Lanes 1–6, integrons detected in strains of Serratia
marcescens SM37, SM38, SM39, SM43 and SM55; lane 7, PA1095; lane 8, PA1115; lane 9, PA1120; lane 10, lambda DNA
HindIII size marker.
Table 3. Ribotyping, epidemiologi-
cal data and integron analysis of
Enterobacter cloacae strains isolated
from the neonatal ICU (episode 3)
Patient Ribotype Strain
Date of
isolation Site of isolation
Integron
RFLP
P1 R4 EC16 07 ⁄ 09 ⁄ 1995 Ocular discharge –
P2 R4 EC18 10 ⁄ 09 ⁄ 1995 Ocular discharge –
P3 R4 EC19 25 ⁄ 08 ⁄ 1995 Ocular discharge –
P4 R4 EC21 29 ⁄ 08 ⁄ 1995 Ocular discharge –
P5 R4 EC23 18 ⁄ 09 ⁄ 1995 Milk –
P6 R5 EC27 02 ⁄ 10 ⁄ 1995 Blood B
P7 R4 EC35 16 ⁄ 10 ⁄ 1995 Milk C
P8 R6 EC36 18 ⁄ 10 ⁄ 1995 Milk D
P9 R4 EC37 18 ⁄ 10 ⁄ 1995 Ocular discharge C
P, patient; R, ribotype; EC, E. cloacae.
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of certain structures, even under strong antibiotic
pressure, suggests the possible use of integron
detection for the characterisation of clinically
important strains. The rapid and precise identiﬁ-
cation of strains potentially involved in cross-
infection episodes in hospital wards is of utmost
importance for the correct implementation of
control measures. In this context, the contribution
of integron detection and characterisation using
restriction analysis as a molecular tool for strain
discrimination was investigated in three episodes
involving an apparently common source of con-
tamination among inpatients of critical wards.
Integron patterns were in agreement with the
results obtained by ribotyping and epidemiolog-
ical data in two of the episodes, while integron
detection and analysis helped to further discrim-
inate isolates involved in the third potential cross-
contamination episode in the NICU.
Susceptibility testing can often provide an
initial indication of the relationship between
bacterial strains, but differential expression of
resistance genes following antibiotic treatment is
an important shortcoming that cannot be over-
looked [38]. In the ﬁrst episode reported here,
differences were observed in antibiotic resistance
between strains that were epidemiologically rela-
ted, while there were common patterns among
unrelated strains. In such cases, the integron
content seemed more consistent with the epide-
miological interpretation of the outbreak, since it
correctly grouped bacteria regarded as respon-
sible for the episode.
The reported association between integrons
and plasmids [13,37] cannot be disregarded. Even
though the plasmid proﬁle itself is often used
successfully for nosocomial epidemiology [39,40],
transfer of plasmids harbouring integrons bet-
ween the same strains or distinct genera can
represent a drawback to the employment of
integron detection and characterisation as a
molecular typing technique. However, in out-
break investigations, the relevant period of study
is usually short, and genetic transfer among the
involved bacteria is rarely observed. Determin-
ation of the integron proﬁle has the advantage of
being easier to perform and more sensitive than
plasmid proﬁling.
Overall, the results of this study suggest that
integron analysis can be considered a useful tool
to monitor cross-infection or identify common
sources of contamination in clinical environ-
ments, ideally in conjunction with other molecu-
lar-based techniques.
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